FR EA

Extract to table

Pull the structured facts out of a document: parties, dates, amounts, obligations.

Extract to table / invalidity-prior-art-analysis-memo.docx
invalidity-prior-art-analysis-memo.docx · 1037-00004

Parties

Harkness LLP
Solstice Biomedical Devices Ltd
Lau LLP
Schering Corp
Kestrel Partners LLC
Teleflex Inc
Demaco Corp
Von Langsdorff Licensing Ltd

Dates

September 18, 2024
November 14, 2017
June 22, 2035
April 30, 2019
September 15, 2036
March 2, 2021
January 10, 2038
October 7, 2024
September 12, 2024
October 22, 2024

Amounts

$184,500

Obligations

To anticipate, a single prior art reference must describe each and every claim limitation and enable a person of ordinary skill in the art to practice the claimed invention without undue experimentation
§ 282, the party challenging validity must establish invalidity by clear and convincing evidence
The inherent disclosure must be certain, not merely probable
Objective indicia of non-obviousness, including commercial success, long-felt need, failure of others, copying, and industry praise, must also be considered
However, any such argument must establish a nexus between the commercial success and the specific patented features—i
The patent specification describes the problem of blade safety in trocar systems: during laparoscopic surgery, the trocar's obturator blade must be sharp enough to penetrate tissue during initial access but must retract into a safe position after penetration to avoid injuring internal organs